Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Anti-thymocyte globulin (rabbit) by Neovii Pharmaceuticals for Myelodysplastic Syndrome: Likelihood of Approval
Anti-thymocyte globulin (rabbit) is under clinical development by Neovii Pharmaceuticals and currently in Phase III for Myelodysplastic Syndrome. According to...
Data Insights
Anti-thymocyte globulin (rabbit) by Neovii Pharmaceuticals for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Anti-thymocyte globulin (rabbit) is under clinical development by Neovii Pharmaceuticals and currently in Phase III for Acute Myelocytic Leukemia (AML,...